Klusmann JH. J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via

CTLA-4/PD-1 blockade. Sci Transl Med 7:315ra188. Christgen M, Winkens W, and Kreipe HH (2014). [Determination of proliferation in breast cancer by immunohistochemical detection of Ki-67]. Pathologe 35:54-60 [...] Schipper E, Christgen H, Kreipe H, Lehmann U, and Christgen M (2013). Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin? PLoS One 8:e73062. Christgen M

Gotina L, Lim S, Jahreis K, Vollbrecht AL, Kim YK, Pae AN, Labus J, Ponimaskin E. Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R. Cell Commun Signal. 2024 [...] Mikesh M, Smith I, Nave KA, Schwab MH, Thompson WJ. Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions. Proc Natl Acad

Pharmacol . Published online August 1, 2025. doi:10.1007/s00210-025-04471-7. Bindel LJ, Seifert R . Determinants of prescribing behaviour of antibacterial drugs in Europe and use of appropriate nomenclature [...] 3390/ijms23042015. Seifert R , Alexander S. Perspective article: A proposal for rational drug class terminology. Br J Pharmacol. 2022; 179(17):4311-4314. doi: 10.1111/bph.15916. Seifert R, Schirmer B . cCMP [...] Viejo-Borbolla A. Generation of hiPSC-derived low threshold mechanoreceptors containing axonal termini resembling bulbous sensory nerve endings and expressing Piezo1 and Piezo2. Stem Cell Res 2021; 56:

Liu, Xiaofei, Norbert Benda, Clemens Mittmann, and Armin Koch . 2024. “Combining Recurrent and Terminal Events Into a Composite Endpoint May Be Problematic.” Statistics in Biopharmaceutical Research 1–8 [...] Grosse. 2023. “Diagnostic Value of Carotid Intima-Media Thickness and Clinical Risk Scores in Determining Etiology of Ischemic Stroke.” European Stroke Journal 8(3):738–46. doi: 10.1177/23969873231182492 [...] 1002/sim.6473. Budde, S., Y. Noll, V. Zieglschmid, C. Schroeder, A. Koch , and H. Windhagen. 2015. “Determination of the Efficacy of EVICELTM on Blood Loss in Orthopaedic Surgery after Total Knee Replacement:

Prozesse weiter zu verbessern, um Wartezeiten so kurz wie möglich zu halten. Sollten Sie einen Untersuchungstermin auf Abruf haben und dennoch die Station (z.B. für die administrative Patientenaufnahme) kurz

specific risk-benefit assessment for subclasses of psychotropic drugs as well as individual drugs are determined and compared with one another. Further, the AMSP project is designed to inform about clinically